Enterprise League logo
Afecta Pharmaceuticals Logo

Afecta Pharmaceuticals

Irvine, United States (US) · Health and Medical

Do your work at Afecta Pharmaceuticals?

Claim this profile to manage your company.

Verified by Enterprise League

Data quality

Complete · Accuracy

Last verified

May 2026

#pharmaceutical

#otc

#small molecules

#neurology

#ophthalmology

#oncology

#dermatology

#drug discovery

#clinical development

#preclinical development

Afecta Pharmaceuticals is a US-based, Irvine, California-focused small molecule therapeutics company developing precision medicines for chronic disorders and cancers.We leverage our proprietary Artificial Intelligence disease/drug targeting platform, PharmetRx®, and innovative drug delivery technology, NanoRx®, to accelerate the discovery and optimization of multi-target drug compounds.Afecta’s approach centers on transforming treatment paradigms for neurological, ophthalmological, oncological, and dermatological conditions, driven by a team of experienced scientists and industry leaders.

Overview

Afecta Pharmaceuticals is a US-based, Irvine, California-focused small molecule therapeutics company developing precision medicines for chronic disorders and cancers.

We leverage our proprietary Artificial Intelligence disease/drug targeting platform, PharmetRx®, and innovative drug delivery technology, NanoRx®, to accelerate the discovery and optimization of multi-target drug compounds.

Afecta’s approach centers on transforming treatment paradigms for neurological, ophthalmological, oncological, and dermatological conditions, driven by a team of experienced scientists and industry leaders. We are currently advancing AFX-220, a clinically proven lead candidate for neurodevelopmental disorders such as Autism and ADHD.

Our collaborations with industry partners, including Supernus Pharmaceuticals and Allergan, underscore our commitment to efficient and impactful drug development.
Visit Official Website

Most teams do this before shortlisting


Contact Details

+1(949) 253-4688
info@afectapharm.com

Irvine, United States (US), 2102 Business Center Dr

Company Type

Private Limited Company

Employees

2-10

Categories

Biopharma
Manufacturing
Pharmaceutical

Keywords

#pharmaceutical

#otc

#small molecules

#neurology

#ophthalmology

#oncology

#dermatology

#drug discovery

#clinical development

#preclinical development

Awards

• 2026 OpenSee all

Products

Default Product Image
AFX-220
Pharmaceutical

AFX-220 is our clinically proven lead candidate, a small molecule therapeutic designed to treat disruptive behaviors associated with neurodevelopmental disorders like Autism and ADHD. It utilizes our NanoRx drug delivery technology for targeted tissue-specific action.

N/A

Companies teams usually look at after Afecta Pharmaceuticals

Comparing a few options usually leads to better decisions






  • Save companies to compare later. Useful when sharing options with your team

This is how your company profile looks to others.